American Water (AWK) Q3 2026 Earnings Call Transcript

American Water Works reported Q3 2026 adjusted EPS of $2.00, up from $1.89 a year earlier, and narrowed 2026 EPS guidance to $6.07–$6.12; standalone 2027 EPS guidance is $6.53–$6.63, implying 8% growth from the 2026 guidance midpoint. Management expects the Essential Utilities merger to close by the end of Q1 2027 and raised its planned capital investment to more than $48 billion through 2035. The Monterey desalination project estimate increased to $825 million plus AFUDC, reflecting permitting and legal delays and higher labor, construction, material and financing costs.

Analysis

Rate-base growth is not automatically earnings growth: the key swing factor is how quickly regulators convert the enlarged investment program into rates while keeping bills affordable. The gap between requested and recommended recovery in Illinois is a useful warning that capital deployment can outpace near-term earnings recognition; if that pattern spreads, depreciation and financing costs arrive before the return. The rising pipe-replacement and PFAS burden therefore supports long-run asset growth but also raises regulatory-lag and affordability risk.

For AWK, the merger is the near-term binary. State settlements and clearance of the federal waiting period reduce execution risk, but the remaining approvals and absent pro forma guidance leave synergy capture, financing and the earnings baseline hard to underwrite. The all-stock structure may improve leverage optics at closing, yet it does not eliminate the combined business’s funding needs; future equity issuance could constrain per-share growth if returns or rate recovery disappoint. WTRG’s standalone outlook is similarly difficult to price until deal terms and post-close treatment of Peoples are clarified.

The main contrarian point: an infrastructure backlog can look like a durable growth engine while functioning as a cash-flow and political constraint first. Near term, the call offers limited new information beyond execution confidence; over 1–3 months, merger decisions and final rate orders matter more. Over 6–18 months, affordability responses, cost control and actual rate-base recovery will test the growth case. Monterey cost escalation is a project-specific caution, not evidence that all AWK projects are overrunning.

Key Decisions for Investors

• No immediate directional position on AWK or WTRG from this call alone: wait for final merger approvals, the exchange terms and combined-company guidance before underwriting relative value. Track the merger spread against the agreed consideration once verified.
• Watch the final Illinois order against the recommended recovery and the company’s requested amount. A materially weaker outcome, or delayed effective rates, would be a falsifier for the assumption that planned capital converts smoothly into EPS growth.
• Treat AWK’s 2029 equity need and planned debt issuance as a dilution/financing watch item, not a near-term short signal. Reassess if leverage fails to improve after closing, financing costs rise, or management revises per-share growth expectations downward.
• Monitor customer-bill affordability and operating-cost trends over the next 6–18 months. If regulators resist pass-through or O&M runs ahead of revenue recovery, consider underweighting AWK versus a diversified utilities exposure such as XLU; absent those signals, avoid forcing a pair trade.